Clinical Trial Update: Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing combination chemotherapy with or without epirubicin for women with stage I or stage II breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Epirubicin (epirubicin)

Snippet

Sponsor: University Hospital Birmingham | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED